IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 174 filers reported holding IMPAX LABORATORIES INC in Q2 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $913,000 | -78.7% | 45,000 | -83.1% | 0.00% | -80.0% |
| Q2 2017 | $4,294,000 | -29.5% | 266,688 | -44.6% | 0.01% | -37.5% |
| Q1 2017 | $6,087,000 | +2.9% | 481,200 | +7.8% | 0.02% | -23.8% |
| Q4 2016 | $5,916,000 | +96.1% | 446,500 | +250.7% | 0.02% | +90.9% |
| Q3 2016 | $3,017,000 | – | 127,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
| NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
| Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
| MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
| SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
| BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
| Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
| Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
| Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
| Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |